Holst, Jens Juul <br/><br/>
Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.  [electronic resource] 

 -  Expert opinion on emerging drugs  May 2004 
 - 155-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7623 
<br/><br/><label>Standard No.: </label>10.1517/eoed.9.1.155.32952  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Deaminase--physiology<br/>Adenosine Deaminase Inhibitors<br/>Afferent Pathways--physiology<br/>Animals<br/>Appetite--drug effects<br/>Diabetes Mellitus, Experimental--drug therapy<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dipeptidyl Peptidase 4--physiology<br/>Drug Therapy, Combination<br/>Exenatide<br/>Glucagon--agonists<br/>Glucagon-Like Peptide 1<br/>Glucagon-Like Peptide-1 Receptor<br/>Glycoproteins--antagonists & inhibitors<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Hypothalamus--drug effects<br/>Insulin--biosynthesis<br/>Insulin Secretion<br/>Intestinal Mucosa--innervation<br/>Islets of Langerhans--drug effects<br/>Liraglutide<br/>Lizards<br/>Maleimides--therapeutic use<br/>Mice<br/>Mice, Knockout<br/>Mice, Obese<br/>Peptide Fragments--agonists<br/>Peptides--pharmacology<br/>Proglucagon<br/>Protein Precursors--agonists<br/>Rats<br/>Rats, Zucker<br/>Receptors, Glucagon--agonists<br/>Venoms--pharmacology